PODCAST · health
Mounjaro vs Ozempic — Which One Works Better?
by Inception Point AI
The SURMOUNT-5 trial just settled the debate: tirzepatide delivered 47% more weight loss than semaglutide in the first major head-to-head study. Dr. Ben Synth analyzes the science behind dual-agonist therapy, dissects the real-world data, and explores what this means for patients choosing between these blockbuster medications.For more content like this, visit QuietPlease.ai
No episodes available yet.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
The SURMOUNT-5 trial just settled the debate: tirzepatide delivered 47% more weight loss than semaglutide in the first major head-to-head study. Dr. Ben Synth analyzes the science behind dual-agonist therapy, dissects the real-world data, and explores what this means for patients choosing between these blockbuster medications.For more content like this, visit QuietPlease.ai
HOSTED BY
Inception Point AI
Loading similar podcasts...
URL copied to clipboard!